Skip to content

Alliance Resource Partners ARLP Pneumoconiosis Benefits

Pneumoconiosis Benefits at other companies

Alpha Metallurgical Resources logo
Alpha Metallurgical ResourcesAMR
$189.53M+4.6%
Alpha Metallurgical Resources logo
Alpha Metallurgical ResourcesAMR
-$4.99M-7.0%
Trimas logo
TrimasTRS
$6.94M+604%
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
$475.12M+26.8%
GATX logo
GATXGATX
-$50K+75.0%
Constellium logo
ConstelliumCSTM
$14M+7.7%

Other financials

Income statement

See full
Revenue$516.0M-4.5%
Operating income$21.9M-76.8%
Net income$9.1M-87.7%
EPS (diluted)$0.07-87.7%

Balance sheet

See full
Cash & equivalents$28.9M-64.5%
Total debt$507.8M+5.3%
Total assets$2.9B-1.6%

Cash flow

See full
Operating cash flow$105.5M-27.6%
CapEx$95.7M+10.3%
Free cash flow$9.8M-83.3%

Valuation

See full
Market cap$3.16B+1.5%
Enterprise value$3.64B+3.4%
P/E12.8×+1.6×
P/S1.5×+0.1×

Profitability

See full
Gross margin36.6%
Operating margin14.4%+0.4pp
Net margin11.3%-0.5pp
FCF margin15.6%+0.7pp

Returns & leverage

See full
Current ratio1.5×-0.5×

Where this comes from

Reported directly by Alliance Resource Partners in its filing.

Tagged under the XBRL concept arlp:PneumoconiosisBenefits.

The official record: Alliance Resource Partners’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alliance Resource Partners's pneumoconiosis benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alliance Resource Partners's pneumoconiosis benefits?
Alliance Resource Partners (ARLP) reported pneumoconiosis benefits of $101.74M in Q1 2026.
How has Alliance Resource Partners's pneumoconiosis benefits changed year-over-year?
Alliance Resource Partners's pneumoconiosis benefits decreased by 16.3% year-over-year, from $121.6M to $101.74M.
What is the long-term trend for Alliance Resource Partners's pneumoconiosis benefits?
Over 5 years (2020 to 2025), Alliance Resource Partners's pneumoconiosis benefits has grown at a -0.8% compound annual growth rate (CAGR), from $105.07M to $100.74M.
What does pneumoconiosis benefits mean?
This metric quantifies the long-term actuarial liability associated with providing health benefits for employees suffering from pneumoconiosis. It represents a significant long-term financial commitment tied to the company's historical mining operations. Investors monitor this to assess the company's long-term social and financial responsibility regarding occupational health.